| 000 | 01850 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514183756.0 | ||
| 264 | 0 | _c20040817 | |
| 008 | 200408s 0 0 eng d | ||
| 022 | _a1040-0605 | ||
| 024 | 7 |
_a10.1152/ajplung.00291.2003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTang, Jen-Ruey | |
| 245 | 0 | 0 |
_aInhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. _h[electronic resource] |
| 260 |
_bAmerican journal of physiology. Lung cellular and molecular physiology _cAug 2004 |
||
| 300 |
_aL344-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 |
_aBronchopulmonary Dysplasia _xdrug therapy |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aNitric Oxide _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xmetabolism |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type III |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPulmonary Alveoli _xdrug effects |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors |
| 700 | 1 | _aMarkham, Neil E | |
| 700 | 1 | _aLin, Yuh-Jyh | |
| 700 | 1 | _aMcMurtry, Ivan F | |
| 700 | 1 | _aMaxey, Anne | |
| 700 | 1 | _aKinsella, John P | |
| 700 | 1 | _aAbman, Steven H | |
| 773 | 0 |
_tAmerican journal of physiology. Lung cellular and molecular physiology _gvol. 287 _gno. 2 _gp. L344-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajplung.00291.2003 _zAvailable from publisher's website |
| 999 |
_c14779877 _d14779877 |
||